UK to undertake world-first COVID-19 alternating vaccine dose study
The UK is undertaking the world’s first clinical trial that aims to determine the safety and effects of using different vaccines for the first...
Oxford vaccine data suggests it reduces COVID-19 transmission
New data on the Oxford/AstraZeneca vaccine has suggested that it may have a substantial impact on transmission of COVID-19.
Analyses of PCR positive swabs from...
Long COVID or mental burnout? Life beyond the pandemic
In this article, Pharma Nord discusses the long-term health impacts of the COVID-19 pandemic.
The first vaccines have been administered in the UK, hopefully spelling...
Researchers identify rare genetic syndrome caused by gene mutations
A new study has identified variation in the gene SATB1 which has been shown to cause a rare genetic syndrome.
Advances in DNA sequencing have...
Study shows vitamins, steroids, and antivirals may combat COVID-19
A new study has indicated that some vitamins, steroids, and antivirals may effectively help to combat COVID-19 by binding to the spike protein and...
Global opioid stewardship and managing chronic pain in children
The World Health Organization (WHO) has issued new guidelines for managing chronic pain in children and highlighted the importance of opioid stewardship to address...
Valneva COVID-19 vaccine production begins in Scotland
Vaccine company Valneva has begun manufacturing of its COVID-19 vaccine candidate in Livingston, West Lothian, Scotland.
The UK government made a joint multi-million pound investment...
Breakthrough to target care for deadly hypertrophic cardiomyopathy
Researchers have made a groundbreaking discovery of new genetic faults in patients living with the deadly heart condition hypertrophic cardiomyopathy (HCM) which could help...
UK offers genomics expertise to find new COVID-19 variants
The UK will be using its world-leading genomic expertise to help countries who do not have the resources to identify new variants of coronavirus.
Countries...
New study to investigate COVID-19 links to hearing loss
A major UK study is set to launch that will investigate the possible long-term impact of COVID-19 on hearing.
The one year study, led by...
Lateral flow rapid tests: a solution for future infectious disease testing
Abingdon Health explores why the use of lateral flow rapid tests during the COVID-19 pandemic may benefit future testing programmes
Machine learning identifies type of autism with 100% accuracy
Researchers have used machine learning to identify patterns of maternal autoantibodies associated with autism, predicting a type of autism in offspring with 100% accuracy.
The...
A novel treatment for cytokine storm
Tetra Bio-Pharma’s drug ARDS-003 has been cleared by the FDA for human trials to target sepsis and ARDS.
IT has been months in the making,...
Exercising muscle helps to combat chronic inflammation
A new study has shown that human muscle can ward off the damaging effects of chronic inflammation when exercised.
Carried out by biomedical engineers at...
Variability in T cells response to COVID-19 could offer clues to immunity
New research has uncovered clues to COVID-19 immunity by looking at how T cells respond to the virus.
A team of researchers from La Jolla...
Global demand for cancer surgery to grow in the next 20 years
The global demand for cancer surgery is expected to increase from 9.1 million to 13.8 million procedures over the next 20 years, according to...
Third of pregnant women not vaccinated against whooping cough
New research has shown that despite whooping cough being highly contagious and serious for new-born babies, up to one third of women in the...
New mechanisms discovered in identification of cancer growth
A team of researchers have discovered new mechanisms which help to understand the growth and treatment of colorectal cancer.
As part of a Cancer Research...
Reducing air pollution could prevent more than 50,000 deaths a year
A new study has shown that reducing air pollution to levels recommended by the World Health Organization (WHO) would prevent more than 50,000 deaths...
Reducing cardiovascular and cerebrovascular deaths with AstraZeneca
AstraZeneca’s recent THALES Phase III trial has demonstrated the efficacy of the drug Brilinta for reducing the risk of major cardiovascular events such as...
